This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Intellicheck Mobilisa, Inc. (IDN) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
IDNPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Advanced Energy (AEIS) Moves 3.6% Higher: Will This Strength Last?
by Zacks Equity Research
Advanced Energy (AEIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AEISPositive Net Change ASMLNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Ouster (OUST) Surges 7.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
Ouster (OUST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OUSTNegative Net Change AMSCPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Applied Optoelectronics (AAOI) Moves 17.8% Higher: Will This Strength Last?
by Zacks Equity Research
Applied Optoelectronics (AAOI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AAOIPositive Net Change ICHRPositive Net Change VTLEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Stora Enso Oyj (SEOAY): Can Its 11.3% Jump Turn into More Strength?
by Zacks Equity Research
Stora Enso Oyj (SEOAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SEOAYNegative Net Change USMNegative Net Change AMSCPositive Net Change IPNegative Net Change ICHRPositive Net Change VTLEPositive Net Change NXTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Gogo (GOGO) Moves 14.9% Higher: Will This Strength Last?
by Zacks Equity Research
Gogo (GOGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GOGOPositive Net Change USMNegative Net Change ICHRPositive Net Change VTLEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Oscar Health (OSCR) Soars 7.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Oscar Health (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OSCRNegative Net Change MBIPositive Net Change VNOMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in PACS Group, Inc. (PACS): Can Its 21.8% Jump Turn into More Strength?
by Zacks Equity Research
PACS Group, Inc. (PACS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
PACSNegative Net Change MBIPositive Net Change VNOMPositive Net Change SHCNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Comstock (CRK): Can Its 9.1% Jump Turn into More Strength?
by Zacks Equity Research
Comstock (CRK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRKNegative Net Change VNOMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Advanced Micro (AMD) Moves 8.8% Higher: Will This Strength Last?
by Zacks Equity Research
Advanced Micro (AMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AMDPositive Net Change AGYSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sage Therapeutics (SAGE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SAGEPositive Net Change RDYPositive Net Change VNegative Net Change MTNegative Net Change MSMPositive Net Change CGENPositive Net Change FUBONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Personalis (PSNL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
PSNLPositive Net Change RDYPositive Net Change VNegative Net Change MTNegative Net Change MSMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
After Golden Cross, Diversified Healthcare (DHC)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DHCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Box (BOX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BOXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Canada Goose (GOOS) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
GOOSPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Constellation Energy Corporation (CEG) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
CEGNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Urban Outfitters (URBN) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
URBNPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Nayax (NYAX) Moves 6.5% Higher: Will This Strength Last?
by Zacks Equity Research
Nayax (NYAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NYAXPositive Net Change VNegative Net Change MTNegative Net Change MSMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Roku (ROKU) Surges 10.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Roku (ROKU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ROKUPositive Net Change RDYPositive Net Change VNegative Net Change MTNegative Net Change MSMPositive Net Change FUBONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
EchoStar (SATS) Moves 49.1% Higher: Will This Strength Last?
by Zacks Equity Research
EchoStar (SATS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
SATSNegative Net Change RDYPositive Net Change VNegative Net Change MTNegative Net Change MSMPositive Net Change GILTPositive Net Change CGENPositive Net Change FUBONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Hudson Tech (HDSN) Soars 8.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Hudson Tech (HDSN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
HDSNPositive Net Change MTNegative Net Change MSMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
U.S. Steel (X) Surges 5.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
U.S. Steel (X) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
MTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy Credo Technology Group Holding Ltd. (CRDO) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CRDONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
AMRNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ACOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines